Ocrelizumab and Other CD20

Gelfand, Jeffrey M

Ocrelizumab and Other CD20 [electronic resource] - Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics Oct 2017 - 835-841 p. digital

Publication Type: Journal Article; Review

1878-7479

10.1007/s13311-017-0557-4 doi


Antibodies, Monoclonal, Humanized--therapeutic use
Antigens, CD20--immunology
B-Lymphocytes--drug effects
Clinical Trials as Topic
Disease Progression
Humans
Immunologic Factors--therapeutic use
Multiple Sclerosis--drug therapy
Treatment Outcome